This inventor holds 2 USPTO granted patents. Top assignees: Eureka Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Tri-Institutional Therapeutics Discovery Institute. Active years: 2026.
Company Filing History:
1 out of 52 
1 out of 618 
1 out of 11 Years Active: 2026
Title: Dharmarao Thapi: Innovator in Antibody Development
Introduction
Dharmarao Thapi is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies.
Latest Patents
Thapi holds a patent titled "Humanized Antibodies to Mucin-16 and Methods of Use Thereof." This patent represents his innovative approach to creating therapeutic antibodies that target specific proteins associated with various diseases.
Career Highlights
Currently, Dharmarao Thapi is employed at Eureka Therapeutics, Inc., where he continues to advance research in antibody technology. His work is pivotal in the development of new treatments that can improve patient outcomes.
Collaborations
Thapi collaborates with several professionals in his field, including his coworker David Spriggs. Their combined expertise contributes to the innovative projects at Eureka Therapeutics.
Conclusion
Dharmarao Thapi's work in the field of humanized antibodies showcases his dedication to advancing medical science. His contributions are essential for the development of new therapeutic options.